Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis
- PMID: 25337995
- PMCID: PMC4206451
- DOI: 10.1371/journal.pone.0110922
Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis
Abstract
Background: Few studies have examined the association of rheumatoid arthritis (RA) with nontuberculosis mycobacterium (NTM) disease and pulmonary tuberculosis (PTB).
Methods: We identified 29 131 patients with RA from the catastrophic illness registry who were diagnosed from 1998-2008; 116 524 patients without RA from inpatient data files were randomly frequency matched according to sex, age, and index year and used as a comparison group. Both groups were followed-up until the end of 2010 to measure the incidence of NTM disease and active PTB. We analyzed the risk of NTM disease and active PTB using the Cox proportional hazards regression models, controlling for sex, age, and Charlson comorbidity index (CCI).
Results: The incidence of NTM disease was 4.22 times greater in the RA group than in the non-RA group (1.91 vs 0.45 per 10,000 person-years). The incidence of PTB was 2.99 times greater in the RA group than in the non-RA group (25.3 vs 8.46 per 10,000 person-years). After adjusting for age, sex, and CCI, the adjusted hazard ratios (HRs) of NTM disease and active PTB for the RA group were 4.17 (95% CI = 2.61-6.65) and 2.87 (95% CI = 2.55-3.23), respectively, compared with the non-RA group. In the first 2 years of follow-up, the RA group yielded corresponding adjusted HRs of 4.98 and 3.39 compared with the non-RA group. The follow-up time-specific RA group to the non-RA group HR of both the NTM disease and active PTB varied.
Conclusion: This study can serve as a reference for clinical physicians to increase awareness regarding the detection of NTM disease and active PTB in RA patients among the any stage of the clinical course even without CCI.
Conflict of interest statement
Figures


Similar articles
-
Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.Chest. 2014 Sep;146(3):563-572. doi: 10.1378/chest.13-2058. Chest. 2014. PMID: 24384637
-
Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease.Int J Tuberc Lung Dis. 2013 Jul;17(7):928-33. doi: 10.5588/ijtld.12.0675. Int J Tuberc Lung Dis. 2013. PMID: 23743312
-
Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.PLoS One. 2020 Dec 2;15(12):e0243110. doi: 10.1371/journal.pone.0243110. eCollection 2020. PLoS One. 2020. PMID: 33264361 Free PMC article.
-
TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.Sci Rep. 2022 Mar 7;12(1):4003. doi: 10.1038/s41598-022-07968-w. Sci Rep. 2022. PMID: 35256729 Free PMC article.
-
The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies.J Rheumatol. 2015 Dec;42(12):2229-37. doi: 10.3899/jrheum.150057. Epub 2015 Oct 15. J Rheumatol. 2015. PMID: 26472414 Review.
Cited by
-
Drug-drug interactions in the management of non-tuberculous mycobacterial infections.Front Microbiol. 2024 Sep 5;15:1468383. doi: 10.3389/fmicb.2024.1468383. eCollection 2024. Front Microbiol. 2024. PMID: 39301186 Free PMC article. Review.
-
Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study.J Clin Med. 2023 Nov 9;12(22):6998. doi: 10.3390/jcm12226998. J Clin Med. 2023. PMID: 38002613 Free PMC article.
-
Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan.PLoS One. 2016 Apr 11;11(4):e0153217. doi: 10.1371/journal.pone.0153217. eCollection 2016. PLoS One. 2016. PMID: 27064275 Free PMC article.
-
Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection.Front Immunol. 2022 Nov 24;13:931876. doi: 10.3389/fimmu.2022.931876. eCollection 2022. Front Immunol. 2022. PMID: 36505429 Free PMC article. Review.
-
The Rise of Non-Tuberculosis Mycobacterial Lung Disease.Front Immunol. 2020 Mar 3;11:303. doi: 10.3389/fimmu.2020.00303. eCollection 2020. Front Immunol. 2020. PMID: 32194556 Free PMC article. Review.
References
-
- Listing J, Gerhold K, Zink A (2013) The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52: 53–61. - PubMed
-
- Hsia EC, Cush JJ, Matteson EL, Beutler A, Doyle MK, et al. (2013) Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials. Arthritis Care Res (Hoboken) 65: 309–313. - PubMed
-
- Takabayashi K, Hanaoka H (2004) [Collagen diseases with opportunistic infections]. Nihon Rinsho Meneki Gakkai Kaishi 27: 156–163. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical